The bond market has entered a financial twilight zone, and at this point, there doesn't seem to be a smooth way out.Market Insiderread more
"I think (rate cuts) will help, but whether they're going to be sufficient to counter the negative trade pressures and global growth slowdown and impact is debatable," one...Central Banksread more
China has used both monetary and fiscal measures to lift economic activity as its trade war with the U.S. looks set to intensify in the coming months.China Economyread more
Alibaba held a board meeting before its latest quarterly earnings release last week, during which the board decided to postpone the Hong Kong listing, Reuters reported.Technologyread more
President Donald Trump said on Twitter he was postponing a scheduled meeting with Denmark's prime minister because of her lack of interest in discussing a possible sale of...World Politicsread more
The two countries want to smash the civil aerospace duopoly enjoyed by Airbus and Boeing.Aerospace & Defenseread more
Federal Reserve Chairman Jerome Powell is set to deliver his annual speech on Friday at the Jackson Hole, Wyoming symposium, where he's expected to provide more clarity on the...Asia Marketsread more
After Elon Musk touts Tesla solar on Twitter, Walmart sues the electric vehicle and clean energy company over store rooftop panels that ignited.Technologyread more
U.S. and Asian investors poured $3.7 billion into U.K. tech start-ups in the first seven months of 2019, research shows.Technologyread more
Trump said he has "been thinking about payroll taxes for a long time" — and he cautioned that "whether or not we do something now, it's not being done because of recession."Politicsread more
Secretary of State Mike Pompeo privately told business executives and free traders that the trade war could end by the 2020 election and that hurdles to an immediate agreement...2020 Electionsread more
Investors should be wary of biotech stocks moving forward, even as some big names continued their tear on Friday, said CNBC "Fast Money" trader Tim Seymour.
"You have to be cautious," Seymour said.
Read MoreBiotech and small caps outperform
Seymour warned that the fund sat in "overbought territory," saying that it might soon pull back. Trader Brian Kelly agreed, adding that investors might want to take profits on biotech names next week.
Gilead and Amgen both rose more than half a percent on Friday, closing around $102 and $170 per share, respectively.
Trader Steve Grasso said he holds a long position in Clovis, which closed nearly 4 percent lower, around $78 per share, on Friday.
Tim Seymour is long T, BAC, C, DIS, XOM, F, GE, GM, GOOGL, INTC, TUR, EWZ and SUNE. Tim's firm is long BABA, BIDU, KO, MCD, NKE, NOK and SBUX.
Brian Kelly is long BTC=, U.S. dollar, GLD, EEM, CTRL calls, GSG, HYG puts, BBRY and TLT. He is short yuan. Today, he bought EEM.
Steve Grasso is long BA, CLVS, EVGN, FB, GDX, GOOGL, IMMR, KBH, KDUS, MHY, MJNA, PFE, POT, SO, T, TMUS and TWTR. His firm is long AMZN, NE, NEM, OXY, RIG, VALE, AVP, KO, MCD and USO. His kids are long EFG, EFA, EWJ, IJR and SPY.
Guy Adami is long CELG, EXAS and INTC. Guy Adami's wife, Linda Snow, works at Merck.